Peptide vaccine for inducing the production of anti-amyloid...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S185100, C424S190100, C424S245100, C424S247100, C424S248100, C536S023400

Reexamination Certificate

active

08034353

ABSTRACT:
An object of the present invention is to provide a peptide vaccine for preventing and/or treating diseases caused by amyloid β-peptide, such as Alzheimer's disease. The present invention solves the above object by providing a peptide vaccine constructed by inserting a peptide having an amino acid sequence of a cell attachment motif of a cell adhesive molecule to a peptide which consists of a peptide having an amino acid sequence of multiagretope type T-cell epitope, which has been generated immunological memory, or a peptide including the same; an linker peptide; and a peptide having an amino acid sequence of a B cell epitope which is a specific region of amyloid β-peptide or a peptide including the same.

REFERENCES:
patent: 7241606 (2007-07-01), Kubota et al.
patent: 7309696 (2007-12-01), Kucera et al.
patent: 2004/0247612 (2004-12-01), Wang
patent: 2005/0142132 (2005-06-01), Schenk et al.
patent: 1614695 (2006-01-01), None
patent: 9514805 (2005-02-01), None
patent: 9927944 (1999-06-01), None
patent: 0210361 (2002-02-01), None
patent: 02096350 (2002-12-01), None
patent: 03015812 (2003-02-01), None
patent: 03089460 (2003-10-01), None
patent: 2004087767 (2004-10-01), None
Janus C et al. Abeta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 2000; 408:979-982.
Morgan D et al. Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 2000; 408:982-985.
Schenk D et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 1999; 400:173-177.
Solomon B. Immunological approaches as therapy for Alzheimer's disease. Expert Opin. Biol. Ther. 2002; 2(8):907-917.
Vickers JC. A vaccine against Alzheimer's disease: Developments to date. Drugs Aging. 2002; 19(7):487-494.
Agadjanyan et al., Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide, Journal Immunology, 174(3):1580-1586 (2005).
Singh et al., ProPred: prediction of HLA-DR binding sites, Bioinformatics, 17(12):1236-1237 (2001).
Yano, 9. Saibo Ketsugo Hairetsu o Mochiita Eki Kyushusei Peptide Seizai no Sekkei, Atarshii Iryo Kiki Kenkyu, 11:16 along with its excerpt translation (2006).
Yano et al., An ingenious design for peptide vaccines, Vaccine, 23:2322-2326 (2005).
M. Manea, et al., “Polypeptide Conjugates Comprising a β-Amyloid Plaque-Specific Epitope as New Vaccine Structures Against Alzheimer's Disease”, Biopolymers (Peptide Science), Jan. 1, 2004, p. 503-511, vol. 76, No. 6, Wiley Periodicals, Inc.
M. Maier, et al., “Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response”, The Journal of Neuroscience, May 3, 2006, p. 4717-4728, vol. 26, No. 18, Society of Neuroscience.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptide vaccine for inducing the production of anti-amyloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide vaccine for inducing the production of anti-amyloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide vaccine for inducing the production of anti-amyloid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4257633

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.